Athliv Pty Ltd — TTAB Proceedings
Athliv Pty Ltd is a party to 1 TTAB proceedings.
Proceedings
- Proceeding 91273250 — Oppositions, Terminated (filed 2021-11-24) against American Diabetes Association as defendant
Marks in These TTAB Matters
Recent Live Filings
Common TTAB Counterparties
- American Diabetes Association — 1 proceedings
Recent TTAB Timeline
- 2023-05-18: 91273250 — TERMINATED involving American Diabetes Association
- 2023-05-18: 91273250 — BOARD'S DECISION: SUSTAINED involving American Diabetes Association
- 2023-05-18: 91273250 — WITHDRAWAL OF APPLICATION involving American Diabetes Association
- 2023-04-27: 91273250 — SUSP PEND DISP OF OUTSTNDNG MOT involving American Diabetes Association
- 2023-04-24: 91273250 — P'S MOTION FOR SANCTIONS involving American Diabetes Association
- 2023-02-22: 91273250 — SUSPENDED involving American Diabetes Association
- 2023-02-22: 91273250 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving American Diabetes Association
- 2022-12-23: 91273250 — SUSPENDED involving American Diabetes Association
- 2022-12-22: 91273250 — P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving American Diabetes Association
- 2022-11-22: 91273250 — SUSPENDED involving American Diabetes Association
- 2022-11-22: 91273250 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving American Diabetes Association
- 2022-08-10: 91273250 — EXTENSION OF TIME GRANTED involving American Diabetes Association
- 2022-08-09: 91273250 — D'S MOT FOR EXTEN. OF TIME W/ CONSENT involving American Diabetes Association
- 2022-03-15: 91273250 — EXTENSION OF TIME GRANTED involving American Diabetes Association
- 2022-03-14: 91273250 — D'S MOT FOR EXTEN. OF TIME W/ CONSENT involving American Diabetes Association
- 2022-01-10: 91273250 — ANSWER involving American Diabetes Association
- 2021-12-02: 91273250 — PENDING, INSTITUTED involving American Diabetes Association
- 2021-12-02: 91273250 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving American Diabetes Association
- 2021-11-24: 91273250 — FILED AND FEE involving American Diabetes Association